Despite an increasing number of medical journal articles about non-arteritic anterior ischemic optic neuropathy NAION being linked to Ozempic, Wegovy, Mounjaro, and Zepbound, there are still no NAION warnings in the current drug labels here in the United States for these popular drugs.
Here are a couple of recent Drug Injury Law articles relevant to there still being no NAION warnings for Ozempic, Wegovy, Mounjaro, and Zepbound:
Ozempic Eye Side Effect NAION Warnings Update July 2026 (7/28/26)
NAION Linked To Zepbound, Mounjaro, Ozempic, Wegovy: 2026 News Update (5/22/26)
In addition, to put this drug safety issue into context, we point out these two recent medical news reports about NAION being linked to Ozempic, Wegovy, Mounjaro, and Zepbound, as well as the present lack of any warnings for NAION and vision loss in their respective drug labels (as of October 20, 2026):
- “GLP-1s and NAION: Do Patients Need a Warning?“, published online October 2, 2026, by Medscape Medical News
- “GLP-1s may be linked to vision loss, but overall risk ‘very, very low’“, published online October 2, 2026, by Healio Primary Care Optometry News
People with vision loss due to NAION diagnosed while using Ozempic, Wegovy, Mounjaro, or Zepbound have told us they were disappointed there were no NAION warnings. Further, some of those people were downright angry about this failure to warn by Novo (known as “Novo Nordisk” until September 2026) and Eli Lilly, the responsible pharmaceutical companies.
We have been investigating drug injury lawsuits that are being filed against Novo or Eli Lilly for patients who have vision loss due to NAION with Ozempic, Wegovy, Mounjaro, or Zepbound use because there are no NAION warnings in their drug labels in the United States.
People diagnosed with NAION due to Ozempic, Wegovy, Mounjaro, or Zepbound use can submit a Case Evaluation Form online to get a free and confidential review of your potential NAION lawsuit:
Ozempic / Wegovy Vision Loss Case Evaluation Form
Zepbound / Mounjaro Eye Side Effect NAION Case Evaluation Form
Or, you can have drug injury lawyer Tom Lamb review your potential NAION lawsuit by emailing him at TJL@LambLawOffice.com or calling him at 910-256-2971.
In closing, we ask: Why are there still no NAION warnings for doctors or patients who are prescribing and using Ozempic, Wegovy, Mounjaro, or Zepbound in the United States as of October 2026, while there have been warnings about NAION and vision loss added to those drug labels in several other countries around the world?
Mounjaro / Zepbound
Free Case Evaluation
Strictly Confidential, No Obligation
Ozempic / Wegovy / Rybelsus
Free Case Evaluation
Strictly Confidential, No Obligation